Dina Elharouni
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.
Journal: Science translational medicine
Published: October 08, 2025
A dependency map enhanced with next-generation 3D cancer models.
Journal: Nature
Published: February 11, 2025
A compendium of next-generation patient-derived models for diverse cancers.
Journal: Nature
Published: February 08, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.
Journal: Cancer research
Published: June 16, 2024
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
Journal: Journal of neuro-oncology
Published: November 01, 2023
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids.
Journal: IEEE transactions on medical imaging
Published: September 13, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.
Journal: NPJ precision oncology
Published: May 05, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.
Journal: Cancers
Published: December 14, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data.
Journal: Pharmacological research
Published: September 10, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026